The impact of macroautophagy on CD8+ T-cell-mediated antiviral immunity

Immunological Reviews

Volumn 255, Issue 1, 2013, Pages 40-56

  Perot, Brieuc P ^a,b,c   Ingersoll, Molly A ^a,b   Albert, Matthew L ^a,b,d  

^a INSTITUT PASTEUR   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Antigen presentation; CD8+ T lymphocytes; Macroautophagy; Virus

Indexed keywords

BECLIN 1; CD4 ANTIGEN; CELL SURFACE RECEPTOR; CHEMOKINE RECEPTOR CXCR4; EPITOPE; HEMAGGLUTININ; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INITIATION FACTOR 2ALPHA; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; INTERLEUKIN 2; JANUS KINASE 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MEMBRANE COFACTOR PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; PATTERN RECOGNITION RECEPTOR; PROTEIN KINASE R; PROTEIN M2; REACTIVE NITROGEN SPECIES; SIGNAL PEPTIDE; STAT1 PROTEIN; X BOX BINDING PROTEIN 1;

ADAPTIVE IMMUNITY; AGGRESOME; ANTIGEN PRESENTATION; APOPTOSIS; AUTOLYSOSOME; AUTOPHAGOSOME; AUTOPHAGY; CANINE DISTEMPER MORBILLIVIRUS; CD8+ T LYMPHOCYTE; CELL ELONGATION; CELL INTERACTION; CELL MATURATION; CELL ORGANELLE; CELL STRESS; CELL STRUCTURE; CELLULAR IMMUNITY; CHIKUNGUNYA ALPHAVIRUS; CROSS PRESENTATION; CYTOTOXIC T LYMPHOCYTE; ENDOPLASMIC RETICULUM STRESS; ENDOSOME; FIBROBLAST; GLUCOSE METABOLISM; HUMAN CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE EVASION; IMMUNE RESPONSE; IMMUNOGENICITY; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; LYSOSOME; MACROAUTOPHAGY; MACROPHAGE; MEASLES VIRUS; MELANOMA CELL; MITOPHAGY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE; T LYMPHOCYTE ACTIVATION; UBIQUITINATION; UNFOLDED PROTEIN RESPONSE; VIRAL CLEARANCE; VIRION; VIRUS ENTRY; VIRUS INACTIVATION; VIRUS INFECTION; VIRUS REPLICATION; XENOPHAGY;

ANTIGEN PRESENTATION; CD8+ T LYMPHOCYTES; MACROAUTOPHAGY; VIRUS;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, VIRAL; AUTOPHAGY; CD8-POSITIVE T-LYMPHOCYTES; CROSS-PRIMING; EPITOPES, T-LYMPHOCYTE; HUMANS; IMMUNITY, INNATE; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTE SUBSETS; VIRUS DISEASES; VIRUSES;

EID: 84881635380     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12096     Document Type: Review

References (156)

1. Yang Z, Klionsky DJ. Eaten alive: a history of macroautophagy. Nat Cell Biol 2010;12:814-822.
2. Joubert PE, Albert ML. Antigen cross-priming of cell-associated proteins is enhanced by macroautophagy within the antigen donor cell. Front Immunol 2012;3:61.
3. He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 2009;43:67-93.
4. Deretic V, Levine B. Autophagy, immunity, and microbial adaptations. Cell Host Microbe 2009;5:527-549.
5. Richetta C, Faure M. Autophagy in antiviral innate immunity. Cell Microbiol 2013;15:368-376.
6. Choi AM, Ryter SW, Levine B. Autophagy in human health and disease. N Engl J Med 2013;368:1845-1846.
7. Klionsky DJ, et al. A unified nomenclature for yeast autophagy-related genes. Dev Cell 2003;5:539-545.
8. Levine B, Klionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 2004;6:463-477.
9. Tooze SA, Yoshimori T. The origin of the autophagosomal membrane. Nat Cell Biol 2010;12:831-835.
10. Hamasaki M, et al. Autophagosomes form at ER-mitochondria contact sites. Nature 2013;495:389-393.
11. Hyttinen JM, Niittykoski M, Salminen A, Kaarniranta K. Maturation of autophagosomes and endosomes: a key role for Rab7. Biochim Biophys Acta 2013;1833:503-510.
12. Itakura E, Kishi-Itakura C, Mizushima N. The hairpin-type tail-anchored SNARE syntaxin 17 targets to autophagosomes for fusion with endosomes/lysosomes. Cell 2012;151:1256-1269.
13. Fimia GM, Kroemer G, Piacentini M. Molecular mechanisms of selective autophagy. Cell Death Differ 2013;20:1-2.
14. Dong X, Levine B. Autophagy and viruses: adversaries or allies? J Innate Immun 2013;5:480-493.
15. Mintern JD, Villadangos JA. Autophagy and mechanisms of effective immunity. Front Immunol 2012;3:60.
16. Yatim N, Albert ML. Dying to replicate: the orchestration of the viral life cycle, cell death pathways, and immunity. Immunity 2011;35:478-490.
17. Jordan TX, Randall G. Manipulation or capitulation: virus interactions with autophagy. Microbes Infect 2012;14:126-139.
18. Chiramel AI, Brady NR, Bartenschlager R. Divergent Roles of Autophagy in Virus Infection. Cell 2013;2:83-104.
19. Santiago C, Celma ML, Stehle T, Casasnovas JM. Structure of the measles virus hemagglutinin bound to the CD46 receptor. Nat Struct Mol Biol 2010;17:124-129.
20. Joubert PE, et al. Autophagy induction by the pathogen receptor CD46. Cell Host Microbe 2009;6:354-366.
21. Denizot M, et al. HIV-1 gp41 fusogenic function triggers autophagy in uninfected cells. Autophagy 2008;4:998-1008.
22. Delpeut S, Rudd PA, Labonte P, von Messling V. Membrane fusion-mediated autophagy induction enhances morbillivirus cell-to-cell spread. J Virol 2012;86:8527-8535.
23. Talloczy Z, et al. Regulation of starvation- and virus-induced autophagy by the eIF2alpha kinase signaling pathway. Proc Natl Acad Sci USA 2002;99:190-195.
24. McFarlane S, Aitken J, Sutherland JS, Nicholl MJ, Preston VG, Preston CM. Early induction of autophagy in human fibroblasts after infection with human cytomegalovirus or herpes simplex virus 1. J Virol 2011;85:4212-4221.
25. Nakamoto M, et al. Virus recognition by Toll-7 activates antiviral autophagy in Drosophila. Immunity 2012;36:658-667.
26. Delgado MA, Elmaoued RA, Davis AS, Kyei G, Deretic V. Toll-like receptors control autophagy. EMBO J 2008;27:1110-1121.
27. Shi CS, Kehrl JH. MyD88 and Trif target Beclin 1 to trigger autophagy in macrophages. J Biol Chem 2008;283:33175-33182.
28. Pattingre S, et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005;122:927-939.
29. Joubert PE, et al. Chikungunya virus-induced autophagy delays caspase-dependent cell death. J Exp Med 2012;209:1029-1047.
30. He B. Viruses, endoplasmic reticulum stress, and interferon responses. Cell Death Differ 2006;13:393-403.
31. Zhang L, Wang A. Virus-induced ER stress and the unfolded protein response. Front Plant Sci 2012;3:293.
32. Gregoire IP, et al. IRGM is a common target of RNA viruses that subvert the autophagy network. PLoS Pathog 2011;7:e1002422.
33. Petkova DS, Viret C, Faure M. IRGM in autophagy and viral infections. Front Immunol 2012;3:426.
34. Takahashi Y, et al. Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nat Cell Biol 2007;9:1142-1151.
35. Kroemer G, Marino G, Levine B. Autophagy and the integrated stress response. Mol Cell 2010;40:280-293.
36. Blanchet FP, et al. Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses. Immunity 2010;32:654-669.
37. Liang C, E X, Jung JU. Downregulation of autophagy by herpesvirus Bcl-2 homologs. Autophagy 2008;4:268-272.
38. Ku B, et al. Structural and biochemical bases for the inhibition of autophagy and apoptosis by viral BCL-2 of murine gamma-herpesvirus 68. PLoS Pathog 2008;4:e25.
39. Marquez RT, Xu L. Bcl-2:Beclin 1 complex: multiple, mechanisms regulating autophagy/apoptosis toggle switch. Am J Cancer Res 2012;2:214-221.
40. de Lima BD, May JS, Marques S, Simas JP, Stevenson PG. Murine gammaherpesvirus 68 bcl-2 homologue contributes to latency establishment in vivo. J Gen Virol 2005;86:31-40.
41. Lee JS, et al. FLIP-mediated autophagy regulation in cell death control. Nat Cell Biol 2009;11:1355-1362.
42. Leidal AM, Cyr DP, Hill RJ, Lee PW, McCormick C. Subversion of autophagy by Kaposi's sarcoma-associated herpesvirus impairs oncogene-induced senescence. Cell Host Microbe 2012;11:167-180.
43. Thome M, et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 1997;386:517-521.
44. Ballon G, Chen K, Perez R, Tam W, Cesarman E. Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice. J Clin Invest 2011;121:1141-1153.
45. Gannage M, et al. Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes. Cell Host Microbe 2009;6:367-380.
46. Pielak RM, Chou JJ. Influenza M2 proton channels. Biochim Biophys Acta 2011;1808:522-529.
47. Rossman JS, Jing X, Leser GP, Lamb RA. Influenza virus M2 protein mediates ESCRT-independent membrane scission. Cell 2010;142:902-913.
48. Zhou Z, et al. Autophagy is involved in influenza A virus replication. Autophagy 2009;5:321-328.
49. Comber JD, Robinson TM, Siciliano NA, Snook AE, Eisenlohr LC. Functional macroautophagy induction by influenza A virus without a contribution to major histocompatibility complex class II-restricted presentation. J Virol 2011;85:6453-6463.
50. de la Calle C, Joubert PE, Law HK, Hasan M, Albert ML. Simultaneous assessment of autophagy and apoptosis using multispectral imaging cytometry. Autophagy 2011;7:1045-1051.
51. Richards AL, Jackson WT. How positive-strand RNA Viruses benefit from autophagosome maturation. J Virol 2013;doi:10.1128/JVI.00460-13.
52. Gil MP, et al. Regulating type 1 IFN effects in CD8 T cells during viral infections: changing STAT4 and STAT1 expression for function. Blood 2012;120:3718-3728.
53. Bahl K, Huebner A, Davis RJ, Welsh RM. Analysis of apoptosis of memory T cells and dendritic cells during the early stages of viral infection or exposure to toll-like receptor agonists. J Virol 2010;84:4866-4877.
54. McNally JM, Zarozinski CC, Lin MY, Brehm MA, Chen HD, Welsh RM. Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses. J Virol 2001;75:5965-5976.
55. Welsh RM, Bahl K, Marshall HD, Urban SL. Type 1 interferons and antiviral CD8 T-cell responses. PLoS Pathog 2012;8:e1002352.
56. Schoenborn JR, Wilson CB. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 2007;96:41-101.
57. Richer MJ, Nolz JC, Harty JT. Pathogen-specific inflammatory milieux tune the antigen sensitivity of CD8(+) T cells by enhancing T cell receptor signaling. Immunity 2013;38:140-152.
58. Freeman BE, Hammarlund E, Raue HP, Slifka MK. Regulation of innate CD8+ T-cell activation mediated by cytokines. Proc Natl Acad Sci USA 2012;109:9971-9976.
59. Lee HK, Lund JM, Ramanathan B, Mizushima N, Iwasaki A. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 2007;315:1398-1401.
60. Ichinohe T, Lee HK, Ogura Y, Flavell R, Iwasaki A. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J Exp Med 2009;206:79-87.
61. Gram AM, Frenkel J, Ressing ME. Inflammasomes and viruses: cellular defence versus viral offence. J Gen Virol 2012;93:2063-2075.
62. Lamkanfi M, Dixit VM. Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol 2012;28:137-161.
63. Lamkanfi M. Emerging inflammasome effector mechanisms. Nat Rev Immunol 2011;11:213-220.
64. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005;5:331-342.
65. Dupont N, Jiang S, Pilli M, Ornatowski W, Bhattacharya D, Deretic V. Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1beta. EMBO J 2011;30:4701-4711.
66. Abrahamsen H, Stenmark H. Protein secretion: unconventional exit by exophagy. Curr Biol 2010;20:R415-R418.
67. Gardella S, et al. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep 2002;3:995-1001.
68. Shi CS, Kehrl JH. TRAF6 and A20 regulate lysine 63-linked ubiquitination of Beclin-1 to control TLR4-induced autophagy. Sci Signal 2010;3:ra42.
69. Ichinohe T, Pang IK, Iwasaki A. Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat Immunol 2010;11:404-410.
70. Chang YP, et al. Autophagy facilitates IFN-gamma-induced Jak2-STAT1 activation and cellular inflammation. J Biol Chem 2010;285:28715-28722.
71. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004;75:163-189.
72. Schroder K, Tschopp J. The inflammasomes. Cell 2010;140:821-832.
73. Matsuzawa T, Kim BH, Shenoy AR, Kamitani S, Miyake M, Macmicking JD. IFN-gamma elicits macrophage autophagy via the p38 MAPK signaling pathway. J Immunol 2012;189:813-818.
74. Li P, et al. Interferon-gamma induces autophagy with growth inhibition and cell death in human hepatocellular carcinoma (HCC) cells through interferon-regulatory factor-1 (IRF-1). Cancer Lett 2012;314:213-222.
75. Loo YM, Gale M Jr. Immune signaling by RIG-I-like receptors. Immunity 2011;34:680-692.
76. Jounai N, et al. The Atg5 Atg12 conjugate associates with innate antiviral immune responses. Proc Natl Acad Sci USA 2007;104:14050-14055.
77. Tal MC, Sasai M, Lee HK, Yordy B, Shadel GS, Iwasaki A. Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling. Proc Natl Acad Sci USA 2009;106:2770-2775.
78. Ke PY, Chen SS. Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro. J Clin Invest 2011;121:37-56.
79. Shi CS, et al. Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol 2012;13:255-263.
80. Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011;469:221-225.
81. Nakahira K, et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 2011;12:222-230.
82. Johansen T, Lamark T. Selective autophagy mediated by autophagic adapter proteins. Autophagy 2011;7:279-296.
83. Ponpuak M, et al. Delivery of cytosolic components by autophagic adaptor protein p62 endows autophagosomes with unique antimicrobial properties. Immunity 2010;32:329-341.
84. Pankiv S, et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 2007;282:24131-24145.
85. Hayden MS, Ghosh S. NF-kappaB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev 2012;26:203-234.
86. Trocoli A, Djavaheri-Mergny M. The complex interplay between autophagy and NF-kappaB signaling pathways in cancer cells. Am J Cancer Res 2011;1:629-649.
87. Fliss PM, et al. Viral mediated redirection of NEMO/IKKgamma to autophagosomes curtails the inflammatory cascade. PLoS Pathog 2012;8:e1002517.
88. Wherry EJ, Ahmed R. Memory CD8 T-cell differentiation during viral infection. J Virol 2004;78:5535-5545.
89. Munz C. Antigen Processing for MHC Class II Presentation via Autophagy. Front Immunol 2012;3:9.
90. Schubert U, Anton LC, Gibbs J, Norbury CC, Yewdell JW, Bennink JR. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 2000;404:770-774.
91. Jensen PE. Recent advances in antigen processing and presentation. Nat Immunol 2007;8:1041-1048.
92. English L, et al. Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection. Nat Immunol 2009;10:480-487.
93. Tey SK, Khanna R. Autophagy mediates transporter associated with antigen processing-independent presentation of viral epitopes through MHC class I pathway. Blood 2012;120:994-1004.
94. Hewitt EW, Gupta SS, Lehner PJ. The human cytomegalovirus gene product US6 inhibits ATP binding by TAP. EMBO J 2001;20:387-396.
95. Lautscham G, Rickinson A, Blake N. TAP-independent antigen presentation on MHC class I molecules: lessons from Epstein-Barr virus. Microbes Infect 2003;5:291-299.
96. Neumeister C, et al. Measles virus and canine distemper virus target proteins into a TAP-independent MHC class I-restricted antigen-processing pathway. J Gen Virol 2001;82:441-447.
97. Reid PA, Watts C. Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments. Nature 1990;346:655-657.
98. Chiu I, Davis DM, Strominger JL. Trafficking of spontaneously endocytosed MHC proteins. Proc Natl Acad Sci USA 1999;96:13944-13949.
99. Mahmutefendic H, Zagorac GB, Tomas MI, Groettrup M, Momburg F, Lucin P. Endosomal trafficking of open Major Histocompatibility Class I conformers-implications for presentation of endocytosed antigens. Mol Immunol 2013;55:149-152.
100. Lautscham G, et al. Identification of a TAP-independent, immunoproteasome-dependent CD8+ T-cell epitope in Epstein-Barr virus latent membrane protein 2. J Virol 2003;77:2757-2761.
101. Tiwari N, Garbi N, Reinheckel T, Moldenhauer G, Hammerling GJ, Momburg F. A transporter associated with antigen-processing independent vacuolar pathway for the MHC class I-mediated presentation of endogenous transmembrane proteins. J Immunol 2007;178:7932-7942.
102. Kleijmeer MJ, et al. Antigen loading of MHC class I molecules in the endocytic tract. Traffic 2001;2:124-137.
103. Gromme M, et al. Recycling MHC class I molecules and endosomal peptide loading. Proc Natl Acad Sci USA 1999;96:10326-10331.
104. Klionsky DJ, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012;8:445-544.
105. Hansen TH, Bouvier M. MHC class I antigen presentation: learning from viral evasion strategies. Nat Rev Immunol 2009;9:503-513.
106. Chaumorcel M, et al. The human cytomegalovirus protein TRS1 inhibits autophagy via its interaction with Beclin 1. J Virol 2012;86:2571-2584.
107. Li B, et al. Autophagy facilitates major histocompatibility complex class I expression induced by IFN-gamma in B16 melanoma cells. Cancer Immunol Immunother 2010;59:313-321.
108. Leung CS, Haigh TA, Mackay LK, Rickinson AB, Taylor GS. Nuclear location of an endogenously expressed antigen, EBNA1, restricts access to macroautophagy and the range of CD4 epitope display. Proc Natl Acad Sci USA 2010;107:2165-2170.
109. Paludan C, et al. Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 2005;307:593-596.
110. Pierre P. Dendritic cells, DRiPs, and DALIS in the control of antigen processing. Immunol Rev 2005;207:184-190.
111. Apcher S, et al. Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation. Proc Natl Acad Sci USA 2011;108:11572-11577.
112. Reits EA, Vos JC, Gromme M, Neefjes J. The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature 2000;404:774-778.
113. Khan S, et al. Cutting edge: neosynthesis is required for the presentation of a T cell epitope from a long-lived viral protein. J Immunol 2001;167:4801-4804.
114. Voo KS, et al. Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes. J Exp Med 2004;199:459-470.
115. Lelouard H, Gatti E, Cappello F, Gresser O, Camosseto V, Pierre P. Transient aggregation of ubiquitinated proteins during dendritic cell maturation. Nature 2002;417:177-182.
116. Szeto J, et al. ALIS are stress-induced protein storage compartments for substrates of the proteasome and autophagy. Autophagy 2006;2:189-199.
117. Lelouard H, et al. Dendritic cell aggresome-like induced structures are dedicated areas for ubiquitination and storage of newly synthesized defective proteins. J Cell Biol 2004;164:667-675.
118. Wenger T, et al. Autophagy inhibition promotes defective neosynthesized proteins storage in ALIS, and induces redirection toward proteasome processing and MHCI-restricted presentation. Autophagy 2012;8:350-363.
119. Herter S, et al. Dendritic cell aggresome-like-induced structure formation and delayed antigen presentation coincide in influenza virus-infected dendritic cells. J Immunol 2005;175:891-898.
120. Joffre OP, Segura E, Savina A, Amigorena S. Cross-presentation by dendritic cells. Nat Rev Immunol 2012;12:557-569.
121. Bertholet S, et al. Leishmania antigens are presented to CD8+ T cells by a transporter associated with antigen processing-independent pathway in vitro and in vivo. J Immunol 2006;177:3525-3533.
122. Shen L, Sigal LJ, Boes M, Rock KL. Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. Immunity 2004;21:155-165.
123. Blachere NE, Darnell RB, Albert ML. Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation. PLoS Biol 2005;3:e185.
124. Albert ML. Death-defying immunity: do apoptotic cells influence antigen processing and presentation? Nat Rev Immunol 2004;4:223-231.
125. Castellino F, et al. Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways. J Exp Med 2000;191:1957-1964.
126. Cooney R, et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med 2010;16:90-97.
127. Lee HK, et al. In vivo requirement for Atg5 in antigen presentation by dendritic cells. Immunity 2010;32:227-239.
128. Li H, Li Y, Jiao J, Hu HM. Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response. Nat Nanotechnol 2011;6:645-650.
129. Johnstone C, Ramos M, Garcia-Barreno B, Lopez D, Melero JA, Del Val M. Exogenous, TAP-independent lysosomal presentation of a respiratory syncytial virus CTL epitope. Immunol Cell Biol 2012;90:978-982.
130. Fiegl D, et al. Amphisomal route of MHC class I cross-presentation in bacteria-infected dendritic cells. J Immunol 2013;190:2791-2806.
131. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998;392:86-89.
132. Uhl M, Kepp O, Jusforgues-Saklani H, Vicencio JM, Kroemer G, Albert ML. Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells. Cell Death Differ 2009;16:991-1005.
133. Li Y, Wang LX, Yang G, Hao F, Urba WJ, Hu HM. Efficient cross-presentation depends on autophagy in tumor cells. Cancer Res 2008;68:6889-6895.
134. Li Y, et al. Tumor-derived autophagosome vaccine: mechanism of cross-presentation and therapeutic efficacy. Clin Cancer Res 2011;17:7047-7057.
135. Li Y, et al. The vitamin E analogue alpha-TEA stimulates tumor autophagy and enhances antigen cross-presentation. Cancer Res 2012;72:3535-3545.
136. Fu X, Tao L, Zhang X. A short polypeptide from the herpes simplex virus type 2 ICP10 gene can induce antigen aggregation and autophagosomal degradation for enhanced immune presentation. Hum Gene Ther 2010;21:1687-1696.
137. Green DR, Ferguson T, Zitvogel L, Kroemer G. Immunogenic and tolerogenic cell death. Nat Rev Immunol 2009;9:353-363.
138. Michaud M, et al. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 2011;334:1573-1577.
139. Pua HH, Dzhagalov I, Chuck M, Mizushima N, He YW. A critical role for the autophagy gene Atg5 in T cell survival and proliferation. J Exp Med 2007;204:25-31.
140. He MX, McLeod IX, Jia W, He YW. Macroautophagy in T lymphocyte development and function. Front Immunol 2012;3:22.
141. Pyo JO, et al. Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death. J Biol Chem 2005;280:20722-20729.
142. Yousefi S, et al. Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat Cell Biol 2006;8:1124-1132.
143. Wildenberg ME, et al. Autophagy attenuates the adaptive immune response by destabilizing the immunologic synapse. Gastroenterology 2012;142(1493-1503):e1496.
144. Paul S, Kashyap AK, Jia W, He YW, Schaefer BC. Selective autophagy of the adaptor protein Bcl10 modulates T cell receptor activation of NF-kappaB. Immunity 2012;36:947-958.
145. Hubbard VM, Valdor R, Patel B, Singh R, Cuervo AM, Macian F. Macroautophagy regulates energy metabolism during effector T cell activation. J Immunol 2010;185:7349-7357.
146. Kovacs JR, et al. Autophagy promotes T-cell survival through degradation of proteins of the cell death machinery. Cell Death Differ 2012;19:144-152.
147. Stephenson LM, et al. Identification of Atg5-dependent transcriptional changes and increases in mitochondrial mass in Atg5-deficient T lymphocytes. Autophagy 2009;5:625-635.
148. Jia W, He YW. Temporal regulation of intracellular organelle homeostasis in T lymphocytes by autophagy. J Immunol 2011;186:5313-5322.
149. Fox CJ, Hammerman PS, Thompson CB. Fuel feeds function: energy metabolism and the T-cell response. Nat Rev Immunol 2005;5:844-852.
150. Sena LA, et al. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity 2013;38:225-236.
151. Killian MS. Dual role of autophagy in HIV-1 replication and pathogenesis. AIDS Res Ther 2012;9:16.
152. Laurent-Crawford AG, et al. Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. AIDS Res Ther 1993;9:761-773.
153. Zhou D, Spector SA. Human immunodeficiency virus type-1 infection inhibits autophagy. AIDS 2008;22:695-699.
154. Espert L, et al. Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. J Clin Invest 2006;116:2161-2172.
155. Espert L, et al. Differential role of autophagy in CD4 T cells and macrophages during X4 and R5 HIV-1 infection. PLoS ONE 2009;4:e5787.
156. Twitty CG, Jensen SM, Hu HM, Fox BA. Tumor-derived autophagosome vaccine: induction of cross-protective immune responses against short-lived proteins through a p62-dependent mechanism. Clin Cancer Res 2011;17:6467-6481.